The global JE (Japanese Encephalitis) vaccine market was estimated to value at USD 215.15 million in 2024. It is expected to grow at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2025-2034 to reach a value of USD 348.34 million in 2034. Japanese Encephalitis (JE) is a serious and potentially fatal viral infection, spread primarily by mosquitoes, which affects both...